ArriVent BioPharma, Correlations

AVBP Stock

29.11 0.37 1.29%

The current 90-days correlation between ArriVent BioPharma, and Sphere Entertainment Co is 0.18 (i.e., Average diversification). The correlation of ArriVent BioPharma, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

ArriVent BioPharma, Correlation With Market

Modest diversification

The correlation between ArriVent BioPharma, Common and DJI is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ArriVent BioPharma, Common and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ArriVent BioPharma, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Moving together with ArriVent Stock

0.64	NAMS	NewAmsterdam Pharma	Pair Corr
0.84	PLRX	Pliant Therapeutics	Pair Corr
0.85	PMVP	Pmv Pharmaceuticals	Pair Corr
0.74	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.65	AVTE	Aerovate Therapeutics	Pair Corr
0.71	CRVS	Corvus Pharmaceuticals	Pair Corr

Moving against ArriVent Stock

0.65	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.58	FDMT	4D Molecular Therapeutics	Pair Corr
0.53	NKTX	Nkarta Inc Buyout Trend	Pair Corr
0.46	PEPG	PepGen	Pair Corr
0.44	RGNX	Regenxbio	Pair Corr
0.42	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.32	MNOV	MediciNova	Pair Corr
0.63	ACIU	AC Immune	Pair Corr
0.51	BDTX	Black Diamond Therap	Pair Corr
0.46	ADAP	Adaptimmune Therapeutics	Pair Corr
0.46	COLL	Collegium Pharmaceutical	Pair Corr
0.43	ANEB	Anebulo Pharmaceuticals	Pair Corr
0.43	SYBX	Synlogic	Pair Corr

Related Correlations Analysis

	MGNI	SPHR	WIMI	TV	RSVR	BCE	DGII	NXPL
MGNI		-0.51	-0.47	-0.48	0.44	-0.74	0.52	-0.49	MGNI
SPHR	-0.51		0.35	0.25	-0.06	0.39	0.02	0.07	SPHR
WIMI	-0.47	0.35		0.78	0.04	0.19	0.02	0.08	WIMI
TV	-0.48	0.25	0.78		0.17	0.04	0.11	0.0	TV
RSVR	0.44	-0.06	0.04	0.17		-0.79	0.87	-0.76	RSVR
BCE	-0.74	0.39	0.19	0.04	-0.79		-0.84	0.8	BCE
DGII	0.52	0.02	0.02	0.11	0.87	-0.84		-0.86	DGII
NXPL	-0.49	0.07	0.08	0.0	-0.76	0.8	-0.86		NXPL
	MGNI	SPHR	WIMI	TV	RSVR	BCE	DGII	NXPL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

DGII	+ 0.87	RSVR
NXPL	+ 0.8	BCE
TV	+ 0.78	WIMI
DGII	+ 0.52	MGNI
RSVR	+ 0.44	MGNI
BCE	+ 0.39	SPHR

High negative correlations

NXPL	- 0.86	DGII
DGII	- 0.84	BCE
BCE	- 0.79	RSVR
NXPL	- 0.76	RSVR
BCE	- 0.74	MGNI
SPHR	- 0.51	MGNI

Risk-Adjusted Indicators

There is a big difference between ArriVent Stock performing well and ArriVent BioPharma, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ArriVent BioPharma,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MGNI	2.36	0.14	0.06	0.20	2.94	(2.54)	4.64	(4.86)	21.10
SPHR	2.12	(0.42)	0.00	(0.21)	0.00	0.00	5.06	(4.40)	14.27
WIMI	3.37	0.07	0.01	0.20	4.15	(4.15)	8.42	(6.33)	26.90
TV	2.84	(0.15)	(0.03)	0.00	4.12	(2.68)	5.38	(6.56)	20.33
RSVR	1.76	0.11	0.07	0.18	2.17	(1.91)	3.91	(3.81)	9.49
BCE	0.88	(0.38)	0.00	(3.44)	0.00	0.00	1.53	(1.83)	12.47
DGII	1.56	(0.04)	0.04	0.09	1.74	(1.75)	3.54	(3.10)	12.64
NXPL	3.08	(0.44)	0.00	(21.69)	0.00	0.00	4.88	(7.80)	34.56

ArriVent BioPharma, Corporate Executives

Elected by the shareholders, the ArriVent BioPharma,'s board of directors comprises two types of representatives: ArriVent BioPharma, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ArriVent. The board's role is to monitor ArriVent BioPharma,'s management team and ensure that shareholders' interests are well served. ArriVent BioPharma,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ArriVent BioPharma,'s outside directors are responsible for providing unbiased perspectives on the board's policies.

	Winston MBA	CFO Treasurer	Profile
	Robin MA	CoFounder COO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC